<DOC>
	<DOCNO>NCT02010762</DOCNO>
	<brief_summary>The majority patient Crohn 's disease ( CD ) need undergo surgical bowel resection . Postoperative recurrence disease virtually inevitable continue one challenging therapeutic problem inflammatory bowel disease . Medical treatment prevent recurrence limited effect . Anti-tumor necrosis factor ( TNF ) agent appear promise hamper immunogenicity , side effect high cost . Vitamin D recently receive lot scientific attention find strong anti-inflammatory antifibrotic effect gut liver inflammation . Many CD patient appear deficiency Vitamin D. A control trial prevent relapse CD medical ( surgical ) remission suggest preventive effect Vitamin D marginally miss endpoint lack power . The ultimate proof anti-inflammatory effect Vitamin D CD best study prevention postoperative recurrence .</brief_summary>
	<brief_title>The Effect Vitamin D3 Maintain Surgical Remission Postoperative Crohn 's Disease</brief_title>
	<detailed_description>Our objective study prophylactic effect Vitamin D3 prevent post-operative recurrence Crohn 's disease ( CD ) , endoscopic endpoint 6 month surgery primary outcome . Endoscopy establish surrogate marker future clinical relapse . Secondary objective include clinical recurrence rate 6 month , difference recurrence rate among patient without low Vitamin D level baseline , effect Vitamin D3 quality life parameter , resource use related cost . ANTICIPATED OUTCOME This study provide proof anti-inflammatory effect vitamin D , opinion best studied post-operative setting . Since post-operative recurrence frequent , safe cost-effective therapy highly need indication . The hypothesis patient receive vitamin D treatment le frequent less severe endoscopic recurrence .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Age â‰¥ 18 year , either male female Established CD First second ileocolonic resection ileocolonic anastomosis removal tissue macroscopically affect CD accord surgeon Able give write informed consent Normal level serum calcium inclusion Being able resume oral intake within 2 week surgery Patients visible CD resect Active fistulizing perianal disease ( require anti TNF treatment ) Extensive small bowel resection Third , fourth later ileocolonic resection Patients undergoing ileocoecal resection Lir ! c Trial ( NTR 1150 , http : //www.trialregister.nl/trialreg/admin/rctview.asp ? TC=1150 ) A history primary hyperparathyroidism A history osteoporosis calcium Vitamin D treatment mandatory A history another granulomatous disease ( sarcoidosis , tuberculosis ) Pregnant breastfeeding ( index date ) female patient Patients undergoing resection ileocolonic resection Patients prefer use openlabel vitamin D preparation Patients continue use tan bed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Crohn 's disease</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Postoperative</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Inflammatory bowel disease</keyword>
	<keyword>Gastroenteritis</keyword>
	<keyword>Gastrointestinal Diseases</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Colonic Diseases</keyword>
	<keyword>Intestinal Diseases</keyword>
	<keyword>Pathologic Processes</keyword>
</DOC>